Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Sumitomo Dainippon Pharma Co. v. Emcure Pharmaceuticals, No. 17-1798 (Fed. Cir. Apr. 16, 2018)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1798
Also Docketed
No. 17-1799, No. 17-1800 (consolidated; same document)
Decided
April 16, 2018
Judge
Stoll, J.
Document
Precedential Opinion
Length
13 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This Hatch -Waxman appeal requires us to construe the scope of a claim depict ing a compound’s chemical structure. Although the compound can exist in two diffe r- ent three-dimensional orientations that are mirror images of each other, only one is portrayed in the claim. The district court construed the claim to cover the two three - dimensional orientations in isolation—both the one shown in the claim and its mirror image —as well as mixtures of the two in any ratio . The parties then stipulated to infringement and the entry of an injunction.